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Abstract 
Accumulating evidence implicates Zika virus (ZIKV) in pathogenesis of microcephaly in newborns and Guillain-Barré 
syndrome in adults. However, it remains unclear which viral proteins are responsible for these effects and what are the 
underlying mechanisms of their pathogenic activity. A recent paper by Drs. Zhao and Gallo, and their colleagues at 
University of Maryland in Baltimore used fission yeast for genome-wide analysis of ZIKV proteins. They demonstrated 
cytopathogenic activity for seven ZIKV proteins, anaC, C, prM, M, E, NS2B and NS4A. This activity was shown to be 
dependent on oxidative stress, and for NS4A they demonstrated involvement of the TOR stress-response pathway. 
Taken together, the findings presented in this paper provide the basis for further mechanistic studies that potentially 
can identify therapeutic means to treat neuro and immune complications of ZIKV infection.
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The outbreak of Zika virus (ZIKV), a flavivirus initially 
identified in mid-twentieth century in Uganda, has 
now reached USA and has spread to other countries in 
North and South America where Aedes mosquitoes, 
which transmit the virus, inhabit [1]. The scary feature of 
ZIKV infection concerns its association with microceph-
aly and other birth defects in children born to infected 
mothers [2] and the Guillain-Barré syndrome caused 
by the immune system damaging the peripheral nerves 
in ZIKV-infected adults [3, 4]. This association is likely 
caused by ZIKV-induced damage of developing neurons 
(in microcephaly) and modification of peripheral nerves 
resulting in autoimmune reaction (in Guillain-Barré syn-
drome). Understanding the mechanisms of this damage 
is essential for developing therapeutic treatments, and 
the recent paper by Li et al. [5] makes an important step 
in this direction.
Study with primary human brain samples demon-
strated that ZIKV infects neural stem cells, astrocytes, 
oligodendrocyte precursor cells, and microglia, whereas 
mature neurons were much less susceptible to infection 
[6]. These findings suggest that microcephaly in infants 
with congenital ZIKV infection may be caused by impair-
ment of neural stem cell differentiation. Consistent with 
this mechanism, ZIKV was shown to increase cell death 
and dysregulate cell-cycle progression of neural progeni-
tors [7] via activation of tall-like receptor (TLR) 3 [8]. 
However, the viral protein(s) responsible for this patho-
genic activity remained unknown. Li et  al. expressed 
all 14 structural and non-structural ZIKV proteins and 
peptides in fission yeast under an inducible promoter 
and analyzed the intracellular localization and cyto-
pathic activities of each protein [5]. All but 5 proteins 
(Pr, NS1, NS3, 2K, and NS5) associated with intracel-
lular membranes, mostly with endoplasmic reticulum 
(ER). Of these 9 membrane-associated proteins, 7 (anaC, 
C, prM, M, E, NS2B and NS4A) were found to exert 
cytopathic effects exhibited as defects in cellular prolif-
eration, cell elongation and hypertrophy, nuclear frag-
mentation and cell cycle dysregulation, which resulted 
in cell death. Using a fluorescent dye specific for reactive 
oxygen species (ROS), the authors demonstrated strong 
fluorescence in cells expressing these seven proteins, sug-
gesting that oxidative stress might be responsible for the 
observed cytopathic effect. Given that, at least in yeast, 
ROS induce Target of Rapamycin (TOR) cellular stress 
response [9], Li et  al. followed up their observations 
by analyzing the effect of one of the ZIKV pathogenic 
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proteins, NS4A, on yeast deleted in Tor1 (a key protein 
in the TOR pathway) or in Tip41 (negative regulator of 
the TOR pathway). Deletion of Tor1 abolished NS4A-
induced cell hypertrophy and restored cell growth to nor-
mal. Expression of NS4A in Tip41-deleted cells worsened 
the NS4A-induced growth delay and cell hypertrophy, 
producing cells of spherical morphology. Surprisingly, 
the phenotype of these cells was similar to cells overex-
pressing Tip41, suggesting that NS4A may mimic the 
effect of NS4A, which inhibits the TOR signaling.
Results reported in the paper by Li et al. are provocative 
and raise new important questions. Is pathogenic activity 
of other ZIKV proteins also mediated by TOR? Is it medi-
ated by TOR activation or inhibition? Is this mechanism 
relevant to human cells, and in particular to neural stem 
cells which are susceptible to ZIKV infection? What are 
the molecular mechanisms linking NS4A, and possibly 
other ZIKV proteins, to the TOR pathway? What is the 
connection between induction of ROS by ZIKV proteins 
and the effects on TOR? Some of these questions have 
been addressed in another report published almost at the 
same time as the paper by Li et  al. [10]. In that report, 
the authors screened ZIKV proteins in human fetal neu-
ral stem cells and found that two proteins, NS4A and 
NS4B, inhibited mammalian TOR (mTOR) signaling by 
inhibiting phosphorylation of the Akt kinase, thus upreg-
ulating autophagy and impairing neurogenesis. Inhibi-
tion of Akt-mTOR signaling by ZIKV is consistent with 
the role of this pathway in cortical development [11], 
and provides a mechanistic link between ZIKV infection 
and microcephaly. These results suggest that other ZIKV 
proteins identified by Li et al. [5] exert their pathogenic 
activity via a different mechanism, e.g. induction of ROS.
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